Stem Cell

Stem Cell

Created using Figma
Created using Figma

Letztes Update

16.09.2018

Stammzelle ICO
 Wir erweitern unser Netzwerk mit Experten, Laboren, Kliniken, Krankenhäusern und gemeinnützigen Organisationen. Unser oberstes Ziel ist es, Menschen, die eine Behandlung benötigen, mit den richtigen professionellen Lösungen und Experten für ihre einzigartigen Bedürfnisse zu binden. Da viele andere Dienstleistungen in der modernen Gesellschaft von SCI angeboten werden, denke ich, dass eine solche Verbindung bequem ist und an Ihren Fingerspitzen erfolgen sollte. Was auch immer herkommt, wir können über die Stammzellen-Innovationsanwendung (SCI-Anwendung) sofort eine Verbindung zum Stammzellenspezialisten herstellen, unabhängig davon, woher jeder kommt und wie viele vertrauliche Informationen mit Experten ausgetauscht werden können.
Main-Sale
21.11.2018
17.01.2019
100% abgeschlossen
$2 520 000
100% ziel abgeschlossen
past
  • 1 SCIA
    =
    0.15 USD
Pre-Sale
17.09.2018
09.10.2018
100% abgeschlossen
$2 520 000
100% ziel abgeschlossen
past
Token-Details
Ticker
SCIA
Akzeptierte Währungen
ETH, LIT, BITC
Firmendetails
Eingetragenes Land
Gibraltar
Weitere Details
Plattform
Ethereum
KYC
Ja
Kategorien
Plattform

Über Stem Cell

Stem Cell Innovations (SCI) ist ein Netzwerk aus hoch motivierten Forschern, medizinischen Fachleuten, engagierten Investoren und innovativen Ingenieuren, die zusammenarbeiten, um eine einzigartige Plattform zu schaffen, die zwei der lebensverändernden Innovationen des 21. Jahrhunderts vereint: die Stammzelltechnologie und Blockchain te Technologie.

Seit seiner ersten Gründung Anfang 2013 unter dem Namen Camden RAD, LLC, hat SCI in der weltweiten Forschung und Entwicklung von Stammzellen eine entscheidende Rolle gespielt, und wir haben eigene nationale und internationale Fallstudien durchgeführt, um die Forschung auf diesem spannenden Gebiet voranzutreiben . Die Aktivitäten von SCI auf dem Gebiet der Stammzellforschung haben direkt zu Fortschritten in diesem Bereich sowie zu neuen Stammzellentdeckungen auf der ganzen Welt beigetragen.

Stammzellen sind eine einzigartige Art von Multizellen, die im menschlichen Körper vorkommen. Es ist eine undifferenzierte Ansammlung von Zellen, die unzählige Anwendungen bei der Entwicklung neuer Zellen zur Verwendung bei der Behandlung von Krankheiten und Zuständen, der Erholung und Wiederherstellung von Körperteilen und mit unserer Forschung und Entwicklung auf viele weitere Anwendungen bringen können.

Bisher waren die Untersuchungsbereiche von SCI orthopädische, neurologische und pulmonale Erkrankungen sowie onkologische Stammzellanwendungen. Obwohl die von SCI durchgeführte Forschung Fortschritte in diesen Bereichen der Medizin gemacht hat, verbleiben nach wie vor Hintergrundbeschriftung: Blättern; Hintergrundclip: Randfeld; Hintergrundfarbe: transparent; Hintergrundbild: keine; Hintergrundursprung : padding-box; background-position-x: 0%; background-position-y: 0%; background-repeat: wiederholen; hintergrundgröße: auto; box-size: border-box; color: # 313131; " Es besteht ein unmittelbarer Bedarf an weiterer Forschung und Entwicklung in einem weiten Zusammenhang von Erkrankungen, die Millionen von Menschen auf der ganzen Welt betreffen. Als führendes Unternehmen in der Stammzellenforschung plant SCI, viele weitere Fallstudien zu organisieren und daran teilzunehmen, um Daten zu sammeln, die zur Entwicklung dieses innovativen Feldes verwendet werden können.

Eigenschaften

Derzeit betreiben Krankenhäuser und Organisationen in den Vereinigten Staaten und auf der ganzen Welt Stammzellforschung, um das Feld voranzutreiben. Bis heute weisen die meisten Fallstudien positive Befunde auf. In der klinischen Forschung außerhalb der USA wurden Stammzellen erfolgreich als Behandlungsform eingesetzt. Stammzellbehandlung und -technologie sind nach wie vor auf dem neuesten Stand der medizinischen Forschung und Entdeckung, und wir sagen voraus, dass Stammzellen ein noch wichtigerer Teil der medizinischen Gemeinschaft werden werden.

Neben der weiteren Forschung plant SCI, Stammzellbanken über sein Ökosystem für Stammzellen anzubieten. Eltern können in einer sicheren Anwendung ein Sammlungs-Kit bestellen, die Abholung des Kuriers planen und sich für die Stammzellenlagerung anmelden. Da SCI seinen Nutzern ein weltweites Netzwerk an Stammzellspeicher- und -therapiemöglichkeiten anbieten wird, ist es einzigartig positioniert, um den Prozess des Stammzellbankens für Eltern zu rationalisieren und die Kosten für die Sammlung und Lagerung zu senken

SCI hat eine einzigartige Formel entwickelt, die es unseren Benutzern ermöglicht, eine einzigartige, maßgeschneiderte synthetische Stammzellbehandlung für ihre medizinischen Bedürfnisse zu erwerben. Mit der Zustimmung des Patienten und minimalen Informationen wie Geburtsdatum, Blutgruppe, Allergien, Diagnosen und verschiedenen gesundheitsbezogenen Fragen wird SCI interne, sichere Laborsequenzen ausführen, die in einen von uns entwickelten proprietären Algorithmus eingebunden sind. Der Algorithmus ermöglicht die Strukturierung einer individuell entwickelten, synthetischen Stammzelle für eine Einzelperson, die einer spezifischen Behandlung bedarf. SCI ist stolz auf diese bahnbrechende Technologie und freut sich noch mehr, sie mit der Welt zu teilen. Fortschritte in der Stammzellenforschung und die Zugänglichkeit von SCI werden die Welt zu herausragenden Innovationen für das Leben führen.

& nbsp;

Technische Information

Protecting confidential user information is vital to the success of a system like the one we are proposing. to ensure security and privacy, Stem Cell Innovations will require users signing into the SCIApplication to provide information and generate a unique identifier within the SCI ecosystem. A unique identifier is an alphanumeric string of information that is assigned to a specific piece of data in an electronic database; in this case, the SCI platform and application. users will be given a unique identifier that will be generated using a proprietary algorithm, which will be used and stored using blockchain technology. the SCI unique identifier will act as users’ keys within the SCI network. through cryptographic methods, the data used to generate the key will be kept secret and secure, able to be parsed only by the SCI decoder. unique identifiers enable access to customized stem cell services and therapies offered throughout the expansive SCI network to our users. SCI will provide personalized stem cell solutions to patients using our platform, and as the SCI network and suite of services grow, users who opt into these services will be apprised of advancements and new treatment options as they become available.

SCI plans to run on dual blockchain platforms. the first platform will be built on an ethereum base for token use only, and it will be powered by the eRC20 platform. the second blockchain will be a custom application designed and built by SCI engineers tailored to fit the healthcare environment.
SCI has decided to build its own blockchain for storing and processing patient stem cell records. this customized blockchain is known as SCIChain. SCIChain will use the Hyperledger fabric network, which will be designed to use smart contracts to protect data and ensure only authorized individuals have access to user data. SCI engineers realize that the Hyperledger fabric blockchain has unique functionalities that differ from other blockchain types that fit with the needs of SCI’s vision and product.

Smart contracts are the gatekeepers of the SCIApplication. users will be free to change their settings at will should their treatments change or preferences change. using mathematical equations equal to the eRC20 platform, SCI ensures user privacy. the straightforward validation associated with a blockchain environment is a secure process that ensures data integrity. furthermore, a cryptography public key will be added to the SCIChain and application to promote a higher standard of security. the symmetric-encrypted key used by SCIChain is 2048-bit, which is a supremely secure method of data transformation in today’s technology-based world.

Stem Cell Roadmap

  • white_paper_v1.1.pdf

  • Please check our whitepaper

Aktivität

Anhänger:
2 637
MEDIUM
Tweets:
601
VERY HIGH
30 Tage Wachstum:
Mitglieder:
1 060
LOW
30 Tage Wachstum:
-63

Stem Cell Mannschaft

Verifiziert 86%

Beachtung. Es besteht das Risiko, dass nicht verifizierte Mitglieder nicht Mitglieder des Teams sind

Moe Galal
Chief Executive Officer / Founder
verifiziert
Ben Barel
Chief Operations Officer / Co-Founder
verifiziert
Ali Alrashidi
Chief Technology Officer / Co-Founder
verifiziert
Matt Galal
Chief of Staff / Co-Founder
verifiziert
Kobi Barel
Operations Engineer / Co-Founder
verifiziert
John Glavinovich
Medical Director
verifiziert
Philip Glukhovsky,
Health Informatics Manager
verifiziert
Roger Williams
VP of Marketing
verifiziert
Liz Curlett
VP, PR & Corporate Communications
verifiziert
Candice Kouchache
Business Development
verifiziert
Ahmed Elsantawi
VP of International Human Resources
verifiziert
David Marmon
Web Designer
verifiziert
Rakel Apodaca
Product Manager
unbestätigt
Michelle Chavon
Marketing
unbestätigt

Berater

Verifiziert 33%

Beachtung. Es besteht das Risiko, dass nicht verifizierte Mitglieder nicht Mitglieder des Teams sind

10 ICOs

$5 540 000

Boyan Josic
Advisor
unbestätigt

5 ICO

$7 040 000

Marc X. Ellul
Advisor
unbestätigt
Roger Shortz
Advisor
verifiziert
Pantea Nakieen
Advisor
unbestätigt
Shahab Sajadi
Advisor
verifiziert

2 ICO

$5 040 000

Igor Soshkin
Advisor
unbestätigt

Stem Cell Interviews

Moe Galal
As a team member, сan you tell us about your role in the ICO project?
Provided clarifications, corrections, and data query resolution with study sites Stem Cell Labs; assisted with quality assurance audits. Developed and reviewed clinical reports, progress/status reports, and final study reports. Build Block-chain to construct the healthcare System, the future of healthcare (Stem Cell) with the future of technology (Block-chain). Form Stem Cell Labs Worldwide.

As the previous founder of Global Medical Management, Inc, founded in 2001, I'm able to tap into my vast network in the medical management community to get the word out about SCI and lends my business expertise to the company in a variety of ways. In order to become the premier provider of stem cell services around the world, myself and the team at SCI continue to collaborate, inspire, and innovate at a time when the medical industry needs not only a face lift, but a complete makeover.
What do you think about idea?
With the better part of 2018 behind us, we look toward what the future holds for SCI and the stem cell community at large. Q4 will see the sale and distribution of the ERC-20 tokens through the Ethereum platform which will drive the continued research and development of stem cell therapies, access, engagement, and treatment around the world. With breakthroughs happening in the stem cell industry on a regular basis, it’s important to pay attention to how this complex, yet soon-to-be-highly-accessible treatment options are changing the world. Much work has yet to be done, but here are just some of the exciting things happening in the stem cell industry at large.

Restoring Heart Function
Regeneration is Made Possible
Creating New Life
Making People Healthy Again

SCI Will Bridge the Gap for Research and Application, idea that never been executed. SCI is working to create research opportunities like these and many others and will connect these innovated treatments to the people who could benefit from them the most with the blockchain-based platform that will provide secure and transparent transactions and interactions to procedures, specialists who can provide such treatments, education, insight, and more. Research and development like what we’ve seen in the first half of 2018 encourages our mission and fuels our vision to bring these life-changing therapies and discoveries to people around the world.
Ben Barel
As a team member, сan you tell us about your role in the ICO project?
healthcare professional with over 20 years of experience managing and overseeing corporate operations, human resources, and compliance reporting in a variety of settings As the Coo, a key member of SCI’s leadership team.
I have taken on a vital leadership role in the building, implementing, and overseeing all of SCI’s corporate operations, processes, workflows and procedures. He plays a critical role in helping to shape and guide the future growth and development of the organization.
What do you think about idea?
This is an amazing project that will

1. bring global awareness for stem cell

2. connect everyone (professional, providers, scientists, and users) around the stem cell.

3. Secure user information on blockchain

4. decentralize stem cell records
Ali Alrashidi
As a team member, сan you tell us about your role in the ICO project?
Chief Technology Officer / Co-Founder
I have a background rich in programming and development, I manages SCI’s blockchain platform. My support in furthering academic research in the field of blockchain will allow SCI to grow.
What do you think about idea?
SCI's platform is "Next Generation" Technology, it's paving the way for advancements in Stem Cell & Healthcare on Blockchain. I'm thrilled to be apart of this journey.
Matt Galal
As a team member, сan you tell us about your role in the ICO project?
Stem Cell Innovations is changing the face of health care by expanding access to stem cell research.
What do you think about idea?
SCI, we are devoted to the international research development & implementation of stem cell therapy.
Kobi Barel
As a team member, сan you tell us about your role in the ICO project?
Responsibilities such as problem solving which includes finding the problem , testing the problem solving and concluding the problem is a daily task as an engineer of operations for companies as innovate radiology Imaging and Stem cell Innovations.
What do you think about idea?
We are bringing two complicated but great tools together to form the best next thing out there for everyone else to follow. I take pride that I am involved in a project that will be used 100 years from now!!
John Glavinovich
As a team member, сan you tell us about your role in the ICO project?
John Glavinovich, M.D. -Medical Director
With over 30 years’ experience in hospital-related clinical, management and operational practices, Dr. Glavinovich a non-traditional approach to the work being done by the team
What do you think about idea?
For the past 20 years I've had an extensive interest in alternative and cutting age medicine. I've worked in recent years on a preventative, proactive and restorative approach to medical treatment including Stem Cell Therapy, The Idea of bringing Stem Cell services to a secure network is important for me and patients alike. I'm excited to see this company reach it's potential and change the way people receive Stem Cell Treatment.
Philip Glukhovsky,
As a team member, сan you tell us about your role in the ICO project?
To consult in proper utilization of stem cell technology and new stem cell research. To maintain a streamlined, patient oriented app interface.
What do you think about idea?
Wonderfully innovative and novel approach that will be the beginnings of the future of modern healthcare.
Roger Williams
As a team member, сan you tell us about your role in the ICO project?
My role at SCI is as their VP of Marketing, I'm known for my innovative approach to marketing and my experience will greatly benefit SCI as the company expands it network and services in the stem cell industry.
What do you think about idea?
Over the years I've worked with many startup companies, whether I believed in the cause or not, but when I heard SCI's platform model, I immediately jumped on board, knowing it was going to change the future for regenerative medicine.
Liz Curlett
As a team member, сan you tell us about your role in the ICO project?
Liz is responsible for strategic development and tactical implementation of media production programs for Stem Cell Innovations. Activities include presentation, video and visual content program oversight, and in-person appearances and speaking engagements when needed. Liz works closely with all members of the SCI team, to create effective and engaging content in order to update stakeholders and build the SCI Brand.
What do you think about idea?
I believe SCI is building an elegant, multi-faceted solution to need that is without boarders. While some countries are still deciding how they want to regulate and/or facilitate stem cell therapy, the market projections and growing demand cannot be ignored. In addition, SCI has selected blockchain technology to address additional marketplace inefficiencies and to ensure this solution remains accessible.

I am thrilled to be part of a team and look forward to contributing my time, resources and experience to the SCI mission.
Candice Kouchache
As a team member, сan you tell us about your role in the ICO project?
I work closely with the SCI team/board to ensure the success of the project, helping to develop internal practices and overall support.
What do you think about idea?
The idea of SCI is innovative and fresh, they have combined two of the worlds smartest inventions, creating an application that will change the way people look at “stem cells” & “Blockchain”
Ahmed Elsantawi
As a team member, сan you tell us about your role in the ICO project?
VP of International Human Resources
15 years’ experience in Human Resources allows the company to ensure the organization grows in a sustainable and efficient way.
What do you think about idea?
Stem Cells on Blockchain
Stem Cell Innovations is changing the face of health care by expanding access to stem cell research, development, and treatments around the world using blockchain technology.
David Marmon
As a team member, сan you tell us about your role in the ICO project?
I am the designer of all the different web / presentation components as well as the developer of the website.
What do you think about idea?
Very, very solid idea. Much needed and revolutionary. Being a part of this team continues to be great.
Roger Shortz
As a team member, сan you tell us about your role in the ICO project?
As an advisor with SCI I bring to the table knowledge as a board certified neurosurgeon with decades of experience. I have advanced training and interest in minimally invasive spinal surgery, as well as complicated spinal instrumentation and fusion.
What do you think about idea?
Stem Cell Innovation is bringing two major issues together to solve the problems we as medical professional have currently. Treatment for with Stem Cells is so "taboo" it is difficult to receive, on the other hand privacy for our patients is threaten daily with the lack of Security with HIPPA. Blockchain technology can change all that. Glad to be of assistance in the process.
Shahab Sajadi
As a team member, сan you tell us about your role in the ICO project?
Adviser in the Pharmaciducal aspect , including a detail data comparison of compounding to stem cell treament.
What do you think about idea?
SCI is bring the future of medicine to the public and i am amazed with what we as a company are doing for the upcoming future.
  • Da bei der Aktualisierung von Informationen zeitliche Unterschiede auftreten können, sollten genaue Informationen zu jedem ICO-Projekt über die offizielle Website oder andere Kommunikationskanäle überprüft werden.
  • Diese Informationen sind kein Vorschlag oder Ratschlag für Investitionen in die ICO-Finanzierung. Bitte recherchieren Sie die relevanten Informationen gründlich und entscheiden Sie sich für die Teilnahme von ICO.
  • Wenn Sie der Meinung sind, dass Probleme oder Probleme bei diesem Inhalt behoben werden müssen, oder wenn Sie Ihr eigenes ICO-Projekt zur Aufnahme einreichen möchten, senden Sie uns bitte eine E-Mail.
Bitte lesen Sie den Haftungsausschluss und die Risikowarnung. Zeige Disclaimer und Risikowarnung.